Giancarla Pricolo

Multicentre phase III trial on fludarabine, cytarabine (Ara‐C), and idarubicin <i>versus</i> idarubicin, Ara‐C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients

Domenico Russo, Michele Malagola, Antonio De Vivo et al. · British Journal of Haematology · 2005 · 41 citations · Full text

Hematological Malignancy, Transplantation, Medicine +15

Analysis of feasibility of myeloablative therapy and autologous peripheral stem cell (PBSC) transplantation in the elderly: an interim report

Patrizio Mazza, G. Palazzo, B Amurri et al. · Bone Marrow Transplantation · 1999 · 33 citations

Regenerative Medicine, Cell Therapy, Transplantation +10

Immunity Profiling of COVID-19 Infection, Dynamic Variations of Lymphocyte Subsets, a Comparative Analysis on Four Different Groups

Mario Giosuè Balzanelli, Pietro Distratis, Gianna Dipalma et al. · Microorganisms · 2021 · 29 citations · Full text

Fludarabine, Arabinosyl Cytosine and Idarubicin (FLAI) for Remission Induction in Poor-Risk Acute Myeloid Leukemia

Domenico Russo, Giancarla Pricolo, Mariagrazia Michieli et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2001 · 27 citations

Mixed-phenotype Acute Leukemia, Immunology, Pharmacotherapy +17

Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience

Patrizio Mazza, Antonella Prudenzano, B Amurri et al. · Bone Marrow Transplantation · 2003 · 23 citations

Hematological Malignancy, Transplantation, Marrow Transplantation +12